Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
Aims to boost speed & precision in patient care
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
Subscribe To Our Newsletter & Stay Updated
